{"disease":{"id":"tolerability","name":"tolerability"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01226316","title":"Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":285,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT05142592","title":"Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":196,"lead_sponsor_name":"Nanjing Immunophage Biotech Co., Ltd","has_results":false},{"nct_id":"NCT05556291","title":"Combination of Ertugliflozin And Sitagliptin Efficacy, Safety & Tolerability (CEASE Diabetes) Study","phase":"","overall_status":"COMPLETED","enrollment_count":190,"lead_sponsor_name":"Getz Pharma","has_results":false},{"nct_id":"NCT03702231","title":"Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's Tyrosine Kinase Inhibitor (BTK-I)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":116,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":true},{"nct_id":"NCT05469854","title":"A Study to Investigate the Pharmacokinetics and ECG Effects of Linaprazan Glurate","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":113,"lead_sponsor_name":"Cinclus Pharma AG","has_results":false},{"nct_id":"NCT07518589","title":"Phase 1 Study of Ascending Doses of CMS-D008 in Healthy and Overweight/Obese Adults","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":110,"lead_sponsor_name":"Shenzhen Kangzhe Biotechnology Co., Ltd.","has_results":false},{"nct_id":"NCT06079541","title":"Phase 1 Clinical Study of JMKX003142 Tablets","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":106,"lead_sponsor_name":"Jemincare","has_results":false},{"nct_id":"NCT04691115","title":"Safety, Tolerability and Pharmacokinetics of AM1476 in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":97,"lead_sponsor_name":"AnaMar AB","has_results":true},{"nct_id":"NCT03672604","title":"A Phase 1 Study to Assess the Safety of NLY01 in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":96,"lead_sponsor_name":"Neuraly, Inc.","has_results":false},{"nct_id":"NCT04783545","title":"Phase I Study of VLX-1005 in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":96,"lead_sponsor_name":"Veralox Therapeutics","has_results":false},{"nct_id":"NCT06000891","title":"A Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":84,"lead_sponsor_name":"Zealand Pharma","has_results":false},{"nct_id":"NCT03809052","title":"A First in Human Study to Evaluate the Safety, Tolerability and PK of GB1211 in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":78,"lead_sponsor_name":"Galecto Biotech AB","has_results":true},{"nct_id":"NCT03685708","title":"HEPLISAV-B Hepatitis B Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's-Tyrosine Kinase Inhibitor (BTK-I)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":78,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":true},{"nct_id":"NCT06569758","title":"A Study of GenSci098 in Subjects With Active Thyroid Eye Disease","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":76,"lead_sponsor_name":"Changchun GeneScience Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT04034784","title":"Discrete(TM) Safety Clinical Trial GLAD-01","phase":"NA","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"ARC Medical Inc.","has_results":false},{"nct_id":"NCT02512575","title":"A Single Ascending Dose Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of AZD9567.","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":72,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT05170737","title":"AEF0217 First-in-Human Phase I Study in 3 Parts (Single and Multiple Ascending Doses, and Food Effect) in Healthy Subjects.","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"Aelis Farma","has_results":false},{"nct_id":"NCT07098663","title":"Food Effect, Efficacy and Safety of MKP10241 in Healthy and Obese Adult Participants, With and Without Diabetes","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":68,"lead_sponsor_name":"Mankind Pharma Limited","has_results":false},{"nct_id":"NCT07016802","title":"A Clinical Study of GenSci134 in Healthy Adults and Adult Growth Hormone Deficiency(AGHD)","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":64,"lead_sponsor_name":"Changchun GeneScience Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT07285967","title":"A First-in-Human SAD and MAD Study in Healthy Participants to Evaluate Oral YR011 Tablet","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":64,"lead_sponsor_name":"Hangzhou Yirui Pharmaceutical Technology Co., Ltd","has_results":false},{"nct_id":"NCT05847218","title":"Phase 1 Clinical Trial of RHN-001 in Healthy Adult Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"RH Nanopharmaceuticals","has_results":false},{"nct_id":"NCT05795192","title":"SB17170 Phase1 Trial in Healthy Volunteer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"SPARK Biopharma","has_results":false},{"nct_id":"NCT05143905","title":"A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7503 in Healthy Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT05698095","title":"Pharmacokinetics, Safety, and Tolerability of Intramuscular 5-MeO-DMT in Healthy Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"Usona Institute","has_results":false},{"nct_id":"NCT06539091","title":"Fluzoparib in Combination With Apatinib Mesylate for Maintenance Therapy in Stage III-IV Ovarian Cancer","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":51,"lead_sponsor_name":"Anhui Provincial Hospital","has_results":false},{"nct_id":"NCT05431634","title":"Multiple Dose Study to Determine Safety and Tolerability of ESK-001 in Healthy Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"Alumis Inc","has_results":false},{"nct_id":"NCT06954428","title":"Clinical Trial of Intranasal Delivery of NT-301","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"Nano PharmaSolutions Australia","has_results":false},{"nct_id":"NCT06894875","title":"Effects of Lentil Protein Hydrolysate on Blood Pressure Control, Vascular Function and Exercise Performance","phase":"NA","overall_status":"RECRUITING","enrollment_count":48,"lead_sponsor_name":"Nuritas Ltd","has_results":false},{"nct_id":"NCT03046589","title":"DP13 SAD & MAD in Healthy Male Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Damian Pharma AG","has_results":false},{"nct_id":"NCT06453824","title":"SAD Evaluation of Safety, Tolerability, PK, and PD of MDI-2517 in Healthy Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"MDI Therapeutics, Inc.","has_results":false},{"nct_id":"NCT04535752","title":"A Single and Multiple Ascending Dose Study of ANX009 in Normal Healthy Volunteers (NHV)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Annexon, Inc.","has_results":false},{"nct_id":"NCT05697887","title":"Feasibility, Tolerability and Efficacy of the Ketogenic Diet in Children With Drug-resistant Epilepsy in South Vietnam","phase":"NA","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"Number 2 Children's Hospital, Ho Chi Minh City","has_results":false},{"nct_id":"NCT07226362","title":"A Study Evaluating the Safety, Tolerability and Pharmacokinetics of ASY202 in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"Aspeya Switzerland SA","has_results":false},{"nct_id":"NCT06715163","title":"Evaluation of the Safety and Tolerability of Three Doses of Diamine Oxidase (DAO) in Healthy Volunteers","phase":"NA","overall_status":"COMPLETED","enrollment_count":43,"lead_sponsor_name":"AB Biotek","has_results":false},{"nct_id":"NCT04220073","title":"Phase I Study of Comparing Single Dose JS005 (Recombinant Humanized Monoclonal Antibody Against IL-17A) With Placebo in Tolerability, Safety, Immunogenicity and Pharmacokinetic in Healthy Volunteers","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Shanghai Junshi Bioscience Co., Ltd.","has_results":false},{"nct_id":"NCT03307512","title":"PK and PD Profile of Dance 501 in Healthy, Non-diabetic Subjects With Mild to Moderate Asthma or COPD","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":40,"lead_sponsor_name":"Dance Biopharm Inc.","has_results":false},{"nct_id":"NCT04782271","title":"Safety, Tolerability and Pharmacokinetic Profile of SYL1801 Eye Drops","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Sylentis, S.A.","has_results":false},{"nct_id":"NCT05633147","title":"Effect of Clarithromycin on PK of Linaprazan, Linaprazan on PK of Clarithromycin and Linaprazan on PK of Midazolam","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"Cinclus Pharma Holding AB","has_results":true},{"nct_id":"NCT05044949","title":"Study Evaluating the Safety and Tolerability of a Probioitc","phase":"NA","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"BioGaia AB","has_results":false},{"nct_id":"NCT03239379","title":"A Multiple-Dose Study of Intravenous BNZ132-1-40 in Healthy Adult Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Bioniz Therapeutics","has_results":false},{"nct_id":"NCT07022275","title":"Safety Evaluation of THC-Free Hemp Protein Isolate","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":32,"lead_sponsor_name":"National University of Natural Medicine","has_results":false},{"nct_id":"NCT06633562","title":"A Study to Test the Effects of Nezavist at Different Doses in Healthy Adults","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":32,"lead_sponsor_name":"Lohocla Research Corporation","has_results":false},{"nct_id":"NCT03817346","title":"Study of Ascending Single Oral Dose of GT-002 in Healthy Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Gabather AB","has_results":false},{"nct_id":"NCT05451667","title":"Single-Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of YJ001 in Healthy Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Yuejia Pharmaceuticals (USA), Inc.","has_results":false},{"nct_id":"NCT06242600","title":"Evaluation of Safety and Performance of the CytaCoat Lubricious Infection Prevention (LIP) Foley Catheter","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"CytaCoat AB","has_results":false},{"nct_id":"NCT07293091","title":"Assessing the Appearance of Amino Acids in Circulation Following Consumption of Protein Beverages","phase":"NA","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Midwest Center for Metabolic and Cardiovascular Research","has_results":false},{"nct_id":"NCT06380270","title":"Evaluation of Safety and Human Tolerance of Oral Probiotic Streptococcus Salivarius eK12","phase":"NA","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"Liaquat University of Medical & Health Sciences","has_results":false},{"nct_id":"NCT06879067","title":"Safety, Tolerability and Immune Effects of the Nasal Foralumab in Healthy Human Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"Tiziana Life Sciences LTD","has_results":false},{"nct_id":"NCT05223660","title":"A Phase I Pharmacokinetics Study for KT07 Capsule","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"Yiling Pharmaceutical Inc.","has_results":false},{"nct_id":"NCT06181760","title":"A Study to Evaluate the Safety of Fenretinide in Healthy Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Island Pharmaceuticals","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}